Lymphoma Caused by Intestinal Microbiota
Abstract
:1. Introduction
2. Microbiota and Lymphoma in Animal Models
2.1. Historical Data Indicating That Gut Microbes May Affect Mouse Phenotypes Such as Cancer and Lifespan
2.2. Animal Models of Mucosal-Associated Lymphoid Tissue (MALT) Lymphoma
2.3. Animal Models of Lymphoma and Effects of the Microbiome
3. Mechanism of Microbiota-Induced Lymphomagenesis as Evidenced in Animal Models
3.1. Microbiota Can Directly Initiate Lymphomagenesis
3.2. Microbiota Can Alter Immune Parameters to Affect Lymphomagenesis
4. Conclusions
Author Contributions
Conflicts of Interest
References
- Compare, D.; Nardone, G. Contribution of gut microbiota to colonic and extracolonic cancer development. Dig. Dis. 2011, 29, 554–561. [Google Scholar] [PubMed]
- Westbrook, A.M.; Wei, B.; Braun, J.; Schiestl, R.H. Intestinal mucosal inflammation leads to systemic genotoxicity in mice. Cancer Res. 2009, 69, 4827–4834. [Google Scholar] [CrossRef] [PubMed]
- Westbrook, A.M.; Wei, B.; Braun, J.; Schiestl, R.H. Intestinal inflammation induces genotoxicity to extraintestinal tissues and cell types in mice. Int. J. Cancer 2011, 129, 1815–1825. [Google Scholar]
- Umesaki, Y.; Setoyama, H. Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect. 2000, 2, 1343–1351. [Google Scholar] [CrossRef]
- Tlaskalova-Hogenova, H.; Stepankova, R.; Kozakova, H.; Hudcovic, T.; Vannucci, L.; Tuckova, L.; Rossmann, P.; Hrncir, T.; Kverka, M.; Zakostelska, Z.; et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: Contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol. Immunol. 2011, 8, 110–120. [Google Scholar]
- Faith, J.J.; Rey, F.E.; O’Donnell, D.; Karlsson, M.; Mcnulty, N.R.; Kallstrom, G.; Goodman, A.L.; Gordon, J.I. Creating and characterizing communities of human gut microbes in gnotobiotic mice. ISME J. 2010, 4, 1094–1098. [Google Scholar] [CrossRef]
- Backhed, F.; Ding, H.; Wang, T.; Hooper, L.V.; Koh, G.Y.; Nagy, A.; Semenkovich, C.F.; Gordon, J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad. Sci. USA 2004, 101, 15718–15723. [Google Scholar] [CrossRef] [PubMed]
- Yi, P.; Li, L. The germfree murine animal: an important animal model for research on the relationship between gut microbiota and the host. Vet. Microbiol. 2012, 157, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Bultman, S.J. Emerging roles of the microbiome in cancer. Carcinogenesis 2014, 35, 249–255. [Google Scholar] [CrossRef] [PubMed]
- Arthur, J.C.; Perez-Chanona, E.; Muhlbauer, M.; Tomkovich, S.; Uronis, J.M.; Fan, T.-J.; Campbell, B.J.; Abujamel, T.; Dogan, B.; Rogers, A.B. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012, 338, 120–123. [Google Scholar] [CrossRef] [PubMed]
- Iliev, I.D.; Funari, V.A.; Taylor, K.D.; Nguyen, Q.; Reyes, C.N.; Strom, S.P.; Brown, J.; Becker, A.A.; Fleshner, P.R.; Dubinsky, M. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012, 336, 1314–1317. [Google Scholar] [CrossRef] [PubMed]
- Chassaing, B.; Aitken, J.D.; Gewirtz, A.T.; Vijay-Kumar, M. Gut microbiota drives metabolic disease in immunologically altered mice. Adv. Immunol. 2012, 116, 93–112. [Google Scholar] [PubMed]
- Erdman, S.E.; Poutahidis, T.; Tomczak, M.; Rogers, A.B.; Cormier, K.; Plank, B.; Horwitza, B.H.; Fox, J.G. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am. J. Pathol. 2003, 162, 691–702. [Google Scholar] [CrossRef] [PubMed]
- Haseman, J.K.; Hailey, J.R.; Morris, R.W. Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: A National Toxicology Program update. Toxicol. Pathol. 1998, 26, 428–441. [Google Scholar] [CrossRef] [PubMed]
- Haseman, J.K.; Huff, J.E.; Rao, G.N.; Eustis, S.L. Sources of variability in rodent carcinogenicity studies. Fundam Appl. Toxicol. 1989, 12, 793–804. [Google Scholar] [CrossRef] [PubMed]
- Rao, G.N.; Haseman, J.K.; Grumbein, S.; Crawford, D.D.; Eustis, S.L. Growth, body weight, survival, and tumor trends in F344/N rats during an eleven-year period. Toxicol. Pathol. 1990, 18, 61–70. [Google Scholar] [CrossRef] [PubMed]
- Walburg, H.E., Jr.; Cosgrove, G.E.; Upton, A.C. Influence of microbial environment on development of myeloid leukemia in x-irradiated RFM mice. Int. J. Cancer. 1968, 3, 150–154. [Google Scholar]
- Reliene, R.; Schiestl, R.H. Differences in animal housing facilities and diet may affect study outcomes-a plea for inclusion of such information in publications. DNA Repair 2006, 5, 651–653. [Google Scholar] [CrossRef] [PubMed]
- Fanning, S.L.; Appel, M.Y.; Berger, S.A.; Korngold, R.; Friedman, T.M. The immunological impact of genetic drift in the B10.BR congenic inbred mouse strain. J. Immunol. 2009, 183, 4261–4272. [Google Scholar]
- Stevens, J.C.; Banks, G.T.; Festing, M.F.; Fisher, E.M. Quiet mutations in inbred strains of mice. Trends Mol. Med. 2007, 13, 512–519. [Google Scholar] [CrossRef] [PubMed]
- Rao, G.N.; Crockett, P.W. Effect of diet and housing on growth, body weight, survival and tumor incidences of B6C3F1 mice in chronic studies. Toxicol. Pathol. 2003, 31, 243–250. [Google Scholar] [CrossRef]
- Bleich, A.; Hansen, A.K. Time to include the gut microbiota in the hygienic standardisation of laboratory rodents. Comp. Immunol. Microbiol. Infect. Dis. 2012, 35, 81–92. [Google Scholar] [CrossRef]
- Yamamoto, M.L.; Maier, I.; Dang, A.T.; Berry, D.; Liu, J.; Ruegger, P.M.; Yang, J.-I.; Soto, P.A.; Presley, L.L.; Reliene, R.; et al. Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity. Cancer Res. 2013, 73, 4222–4232. [Google Scholar] [CrossRef] [PubMed]
- Saito, Y.; Suzuki, H.; Tsugawa, H.; Imaeda, H.; Matsuzaki, J.; Hirata, K.; Hosoe, N.; Nakamura, M.; Mukai, M.; Saito, H.; et al. Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One 2012, 7. [Google Scholar] [CrossRef]
- Isaacson, P.G.; Du, M.Q. MALT lymphoma: from morphology to molecules. Nat. Rev. Cancer. 2004, 4, 644–653. [Google Scholar] [PubMed]
- Wotherspoon, A.C.; Ortiz-Hidalgo, C.; Falzon, M.R.; Isaacson, P.G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991, 338, 1175–1176. [Google Scholar] [CrossRef] [PubMed]
- Bayerdorffer, E.; Rudolph, B.; Neubauer, A.; Thiede, C.; Lehn, N.; Eidt, S.; Stolte, M.; Malt Lyphoma Study Group. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995, 345, 1591–1594. [Google Scholar]
- Enno, A.; O'Rourke, J.L.; Howlett, C.R.; Jack, A.; Dixon, M.F.; Lee, A. MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am. J. Pathol. 1995, 147, 217–222. [Google Scholar]
- Hirayama, F.; Takagi, S.; Kusuhara, H.; Iwao, E.; Yokoyama, Y.; Ikeda, Y. Induction of gastric ulcer and intestinal metaplasia in mongolian gerbils infected with Helicobacter pylori. J. Gastroenterol. 1996, 31, 755–757. [Google Scholar] [CrossRef]
- Mueller, A.; O'Rourke, J.; Grimm, J.; Guillemin, K.; Dixon, M.F.; Lee, A.; Falkow, S. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc. Natl. Acad. Sci. USA 2003, 100, 1292–1297. [Google Scholar] [CrossRef] [PubMed]
- O’Rourke, J.L. Gene expression profiling in Helicobacter-induced MALT lymphoma with reference to antigen drive and protective immunization. J. Gastroenterol. Hepatol. 2008, 23, 151–156. [Google Scholar]
- Suzuki, A.; Kobayashi, M.; Matsuda, K.; Matsumoto, T.; Kawakubo, M.; Kumazawa, S.; Koide, N.; Miyagawa, S.; Ota, H. Induction of high endothelial venule-like vessels expressing GlcNAc6ST-1-mediated L-selectin ligand carbohydrate and mucosal addressin cell adhesion molecule 1 (MAdCAM-1) in a mouse model of “Candidatus Helicobacter heilmannii”—induced gastritis and gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Helicobacter 2010, 15, 538–548. [Google Scholar] [CrossRef] [PubMed]
- O’Rourke, J.L.; Dixon, M.F.; Jack, A.; Enno, A.; Lee, A. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of “Helicobacter heilmannii” infection. J. Pathol. 2004, 203, 896–903. [Google Scholar]
- Nakamura, M.; Murayama, S.Y.; Serizawa, H.; Sekiya, Y.; Eguchi, M.; Takahashi, S.; Nishikawa, K.; Takahashi, T.; Matsumoto, T.; Yamada, H. “Candidatus Helicobacter heilmannii” from a cynomolgus monkey induces gastric mucosa-associated lymphoid tissue lymphomas in C57BL/6 mice. Infect. Immun. 2007, 75, 1214–1222. [Google Scholar] [CrossRef] [PubMed]
- Suarez, F.; Lortholary, O.; Hermine, O.; Lecuit, M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006, 107, 3034–3044. [Google Scholar] [CrossRef] [PubMed]
- Gold, J.S.; Bayar, S.; Salem, R.R. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch. Surg. 2004, 139, 760–765. [Google Scholar] [CrossRef] [PubMed]
- Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57–70. [Google Scholar] [CrossRef] [PubMed]
- Newman, J.V.; Kosaka, T.; Sheppard, B.J.; Fox, J.G.; Schauer, D.B. Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J. Infect. Dis. 2001, 184, 227–230. [Google Scholar] [CrossRef] [PubMed]
- Wu, S.; Rhee, K.J.; Albesiano, E.; Rabizadeh, S.; Wu, X.; Yen, H.-R.; Huso, D.L.; Brancati, F.L.; Wick, E.; McAllister, F.; et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 2009, 15, 1016–1022. [Google Scholar] [CrossRef] [PubMed]
- Diwan, B.A.; Ward, J.M.; Ramljak, D.; Anderson, L.M. Promotion by Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosodimethylamine in male A/JCr mice. Toxicol. Pathol. 1997, 25, 597–605. [Google Scholar] [CrossRef] [PubMed]
- Barlow, C.; Hirotsune, S.; Paylor, R.; Liyanage, M.; Eckhaus, M.; Collins, F.; Shiloh, Y.; Crawley, J.N.; Ried, T.; Tagle, D.; et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996, 86, 159–171. [Google Scholar] [CrossRef] [PubMed]
- Reliene, R.; Schiestl, R.H. Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice. DNA Repair 2006, 5, 852–859. [Google Scholar] [CrossRef] [PubMed]
- Fujiwara, D.; Wei, B.; Presley, L.L.; Brewer, S.; McPherson, M.; Lewinki, M.A.; Borneman, J.; Braun, J. Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota. J. Immunol. 2008, 180, 5843–5852. [Google Scholar] [CrossRef] [PubMed]
- Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8, 411–420. [Google Scholar] [CrossRef] [PubMed]
- MacDonald, T.T.; Gordon, J.N. Bacterial regulation of intestinal immune responses. Gastroenterol. Clin. North Am. 2005, 34, 401–412, vii-viii. [Google Scholar]
- Reddy, B.S.; Mangat, S.; Weisburger, J.H.; Wynder, E.L. Effect of high-risk diets for colon carcinogenesis on intestinal mucosal and bacterial beta-glucuronidase activity in F344 rats. Cancer Res. 1977, 37, 3533–3536. [Google Scholar] [PubMed]
- Takada, H.; Hirooka, T.; Hiramatsu, Y.; Yamamoto, M. Effect of beta-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res. 1982, 42, 331–334. [Google Scholar] [PubMed]
- Knasmuller, S.; Steinkellner, H.; Hirschl, A.M.; Rabot, S.; Nobis, E.C.; Kassie, F. Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Mutat. Res. 2001, 480–481, 129–138. [Google Scholar]
- Kassie, F.; Rabot, S.; Kundi, M.; Chabicovsky, M.; Qin, H.M.; Knasmuller, S. Intestinal microflora plays a crucial role in the genotoxicity of the cooked food mutagen 2-amino-3-methylimidazo [4,5-f]quinoline. Carcinogenesis 2001, 22, 1721–1725. [Google Scholar] [CrossRef] [PubMed]
- Hayatsu, H.; Hayatsu, T. Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett. 1993, 73, 173–179. [Google Scholar] [CrossRef] [PubMed]
- Kullisaar, T.; Songisepp, E.; Mikelsaar, M.; Zilmer, K.; Vihalemm, T.; Zilmer, M. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br. J. Nutr. 2003, 90, 449–456. [Google Scholar] [CrossRef] [PubMed]
- Blaser, M.J.; Atherton, J.C. Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 2004, 113, 321–333. [Google Scholar] [CrossRef]
- Arabski, M.; Klupinska, G.; Chojnacki, J.; Kazmierczak, P.; Wisniewska-Jarosinska, M.; Drzewoski, J.; Blasiak, J. DNA damage and repair in Helicobacter pylori-infected gastric mucosa cells. Mutat. Res. 2005, 570, 129–135. [Google Scholar] [CrossRef] [PubMed]
- Smoot, D.T.; Elliott, T.B.; Verspaget, H.W.; Jones, D.; Allen, C.R.; Vernon, K.G.; Bremner, T.; Kidd, C.R.; Kim, K.S.; Groupman, J.D.; et al. Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis 2000, 21, 2091–2095. [Google Scholar] [CrossRef] [PubMed]
- Klinder, A.; Forster, A., .; Caderni, G.; Femia, A.P.; Pool-Zobel, B.L. Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination. Nutr. Cancer 2004, 49, 144–155. [Google Scholar]
- Vieira, J.M.; Seabra, S.H.; Vallim, D.C.; Americo, M.A.; Fracallanza, S.E.L.; Vommaro, R.C.; Domingues, R.M.C.P. Bacteroides fragilis induce necrosis on mice peritoneal macrophages: In vitro and in vivo assays. Biochem. Biophys. Res. Commun. 2009, 387, 627–632. [Google Scholar] [PubMed]
- Kumar, A.; Wu, H.; Collier-Hyams, L.S.; Hansen, J.M.; Li, T.; Yamoah, K.; Pan, Z.-Q.; Jones, D.P.; Neish, A.S. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 2007, 26, 4457–4466. [Google Scholar]
- Ames, B.N.; Shigenaga, M.K.; Hagen, T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 1993, 90, 7915–7922. [Google Scholar] [CrossRef] [PubMed]
- Cerutti, P.; Ghosh, R.; Oya, Y.; Amstad, P. The role of the cellular antioxidant defense in oxidant carcinogenesis. Environ. Health Perspect. 1994, 102, 123–129. [Google Scholar] [CrossRef] [PubMed]
- Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860–867. [Google Scholar] [CrossRef] [PubMed]
- Banks, P.M. Gastrointestinal lymphoproliferative disorders. Histopathology 2007, 50, 42–54. [Google Scholar] [CrossRef] [PubMed]
- Bende, R.J.; Aarts, W.M.; Riedl, R.G.; de Jong, D.; Pals, S.T.; van Noesel, C.J. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 2005, 201, 1229–1241. [Google Scholar] [CrossRef]
- Shanahan, F. Nutrient tasting and signaling mechanisms in the gut V. Mechanisms of immunologic sensation of intestinal contents. Am. J. Physiol. Gastrointest Liver Physiol. 2000, 278, 191–196. [Google Scholar]
- Arimochi, H.; Kinouchi, T.; Kataoka, K.; Kuwahara, T.; Ohnishi, Y. Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochem. Biophys. Res. Commun. 1997, 238, 753–757. [Google Scholar] [CrossRef] [PubMed]
- Hirayama, K.; Rafter, J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000, 2, 681–686. [Google Scholar] [CrossRef]
- Cebra, J.J. Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 1999, 69, 1046–1051. [Google Scholar]
- Hooper, L.V.; Midtvedt, T.; Gordon, J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 2002, 22, 283–307. [Google Scholar] [CrossRef] [PubMed]
- Hooper, L.V.; Gordon, J.I. Commensal host-bacterial relationships in the gut. Science 2001, 292, 1115–1118. [Google Scholar] [CrossRef] [PubMed]
- Wei, B.; Su, T.T.; Dalwadi, H.; Stephan, R.P.; Fujiwara, D.; Huang, T.T.; Brewer, S.; Chen, L.; Arditi, M.; Borneman, J.; et al. Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells. Eur. J. Immunol. 2008, 38, 3411–3425. [Google Scholar]
- Wei, B.; Wingender, G.; Fujiwara, D.; Chen, D.Y.; McPherson, M.; Brewer, S.; Borneman, J.; Kronenberg, M.; Braun, J. Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells. J. Immunol. 2010, 184, 1218–1226. [Google Scholar] [CrossRef] [PubMed]
- Huang, T.; Wei, B.; Velazquez, P.; Borneman, J.; Braun, J. Commensal microbiota alter the abundance and TCR responsiveness of splenic naive CD4+ T lymphocytes. Clin. Immunol. 2005, 117, 221–230. [Google Scholar] [CrossRef] [PubMed]
- Gaboriau-Routhiau, V.; Rakotobe, S.; Lecuyer, E.; Mulder, I.; Lan, A.; Bridonneau, C.; Rochet, V.; Pisi, A.; De Paepe, M.; Brandi, G.; et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31, 677–689. [Google Scholar]
- Mazmanian, S.K.; Liu, C.H.; Tzianabos, A.O.; Kasper, D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122, 107–118. [Google Scholar] [CrossRef] [PubMed]
- Sonnenburg, J.L.; Chen, C.T.; Gordon, J.I. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol. 2006, 4. [Google Scholar] [CrossRef]
- Vannucci, L.; Stepankova, R.; Kozakova, H.; Fiserova, A.; Rossmann, P.; Tlaskalova-Hogenova, H. Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity. Int. J. Oncol. 2008, 32, 609–617. [Google Scholar] [PubMed]
- Ishikawa, H.; Akedo, I.; Otani, T.; Takeyama, I.; Ishiguro, S.; Miyaoka, E.; Sobue, T.; Kakizoe, T. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer. 2005, 116, 762–767. [Google Scholar] [CrossRef] [PubMed]
- Kim, J.E.; Kim, J.Y.; Lee, K.W.; Lee, H.J. Cancer chemopreventive effects of lactic acid bacteria. J. Microbiol. Biotechnol. 2007, 17, 1227–1235. [Google Scholar] [PubMed]
- Kingma, S.D.; Li, N.; Sun, F.; Valladares, R.B.; Neu, J.; Lorca, G.L. Lactobacillus johnsonii N6.2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats. J. Nutr. 2011, 141, 1023–1028. [Google Scholar]
- Valladares, R.; Sankar, D.; Li, N.; Williams, E.; Lai, K.-K.; Abdelgeliel, A.S.; Gonzalez, C.F.; Wasserfall, C.H.; Larkin, J., III; Schatz, D.; et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 5. [CrossRef]
- Matsuzaki, T. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 1998, 41, 133–140. [Google Scholar] [CrossRef] [PubMed]
- Kato, I.; Endo, K.; Yokokura, T. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int. J. Immunopharmacol. 1994, 16, 29–36. [Google Scholar] [CrossRef] [PubMed]
- Kato, I.; Yokokura, T.; Mutai, M. Macrophage activation by Lactobacillus casei in mice. Microbiol. Immunol. 1983, 27, 611–618. [Google Scholar] [CrossRef] [PubMed]
- Rafter, J. Probiotics and colon cancer. Best Pract Res Clin Gastroenterol. 2003, 17, 849–859. [Google Scholar] [CrossRef]
- Smith, P.M.; Howitt, M.R.; Panikov, N.; Michaud, M.; Gallini, C.A.; Bohlooly-Y, M.; Glickman, J.N.; Garrett, W.S. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341, 569–573. [Google Scholar] [CrossRef] [PubMed]
- Arpaia, N.; Campbell, C.; Fan, X.; Dikiy, S.; van der Veeken, J.; deRoos, P.; Liu, H.; Cross, J.R.; Pfeffer, K.; Coffer, P.J.; et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504, 451–455. [Google Scholar]
- Ames, B.N.; Gold, L.S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 1990, 249, 970–971. [Google Scholar] [CrossRef] [PubMed]
- Cohen, S.M.; Ellwein, L.B. Cell proliferation in carcinogenesis. Science 1990, 249, 1007–1011. [Google Scholar] [CrossRef] [PubMed]
- Shaffer, A.L.; Rosenwald, A.; Staudt, L.M. Lymphoid malignancies: the dark side of B-cell differentiation. Nat. Rev. Immunol. 2002, 2, 920–932. [Google Scholar] [CrossRef] [PubMed]
- Pasqualucci, L.; Neumeister, P.; Goossens, T.; Nanjangud, G.; Chaganti, R.S.K.; Kuppers, R.; Dalla-Favera, R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001, 412, 341–346. [Google Scholar] [CrossRef] [PubMed]
- Oliver, A.M.; Martin, F.; Kearney, J.F. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 1999, 162, 7198–7207. [Google Scholar] [PubMed]
- Kullisaar, T.; Zilmer, M.; Mikelsaar, M.; Vihalemm, T.; Annuk, H.; Kairane, C.; Kilk, A. Two antioxidative lactobacilli strains as promising probiotics. Int. J. Food Microbiol. 2002, 72, 215–224. [Google Scholar] [CrossRef] [PubMed]
- Federico, A.; Morgillo, F.; Tuccillo, C.; Ciardiello, F.; Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer. 2007, 121, 2381–2386. [Google Scholar] [CrossRef] [PubMed]
- Epeldegui, M.; Widney, D.P.; Martinez-Maza, O. Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-associated molecular lesions. Curr. Opin. Oncol. 2006, 18, 444–448. [Google Scholar] [CrossRef] [PubMed]
- Illes, A.; Varoczy, L.; Papp, G.; Wilson, P.C.; Alex, P.; Jonsson, R.; Kovacs, T.; Konttinen, Y.T.; Zeher, M.; Nakken, B.; Szodoray, P. Aspects of B-cell non-Hodgkin’s lymphoma development: a transition from immune-reactivity to malignancy. Scand. J. Immunol. 2009, 69, 387–400. [Google Scholar] [PubMed]
- Al-Saleem, T.; Al-Mondhiry, H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood 2005, 105, 2274–2280. [Google Scholar]
- Lecuit, M.; Abachin, E.; Martin, A.; Poyart, C.; Pochart, P.; Suarez, F.; Bengoufa, D.; Feuillard, J.; Lavergne, A.; Gordon, J.I.; et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 2004, 350, 239–248. [Google Scholar] [CrossRef] [PubMed]
- Ferreri, A.J.; Guidoboni, M.; Ponzoni, M.; de Conciliis, C.; Dell’Oro, S.; Fleischhauer, K.; Caggiari, L.; Lettini, A.A.; Clin, E.D.; Leri, R.; et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J. Natl. Cancer Inst. 2004, 96, 586–594. [Google Scholar] [CrossRef]
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Share and Cite
Yamamoto, M.L.; Schiestl, R.H. Lymphoma Caused by Intestinal Microbiota. Int. J. Environ. Res. Public Health 2014, 11, 9038-9049. https://doi.org/10.3390/ijerph110909038
Yamamoto ML, Schiestl RH. Lymphoma Caused by Intestinal Microbiota. International Journal of Environmental Research and Public Health. 2014; 11(9):9038-9049. https://doi.org/10.3390/ijerph110909038
Chicago/Turabian StyleYamamoto, Mitsuko L., and Robert H. Schiestl. 2014. "Lymphoma Caused by Intestinal Microbiota" International Journal of Environmental Research and Public Health 11, no. 9: 9038-9049. https://doi.org/10.3390/ijerph110909038